IMMUNIC, INC. — Form 10-Q
Filed August 11, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 42/100
What the filing says
Immunic hired Jason Tardio as Chief Operating Officer and President effective July 9, 2024, per employment agreement dated July 22, 2024. Compensation includes base salary of $500,000 annually, signing bonus of $60,000, additional $60,000 bonus if employed through January 12, 2025, and annual bonus eligibility of 40% of base salary. Equity awards also granted under 2019 Omnibus Plan. Severance provisions include 12 months base salary plus 50–100% unvested equity vesting (depending on change-of-control timing) and 12 months COBRA reimbursement upon qualifying termination.
Why this rating
C-suite hire is material operationally but modest in cost ($500K base is ~0.6% of $83M market cap). No strategic M&A or go-concern change; routine executive staffing with standard severance package.
See more from August 11, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.